PER 5.13% 7.4¢ percheron therapeutics limited

Good article. Akcea trials antisense drugs that were spun off by...

  1. 505 Posts.
    lightbulb Created with Sketch. 74
    Good article.

    Akcea trials antisense drugs that were spun off by Ionis. Trials were promising and the company now has a market cap of 1.7 billion.

    Pfizer will pay $250 million lisencing fees, milestone payments of up to $1.3billion, royalty fees on sales and take over the remaing trials.

    Akcea and Ionis to share the proceeds.


    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.4¢
Change
-0.004(5.13%)
Mkt cap ! $66.71M
Open High Low Value Volume
7.8¢ 7.8¢ 7.2¢ $78.26K 1.049M

Buyers (Bids)

No. Vol. Price($)
1 5919 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 156164 2
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.